文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

印度西部现代结核分枝杆菌谱系的耐药与流行病学成功

Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India.
PubMed 文献 · J Infect Dis · 2025-01-01

研究对印度浦那612株结核分枝杆菌分离株进行全基因组测序,比较L1-L4谱系的流行病学成功、宿主因素和耐药性。结果显示L3占44.6%,61.1%的耐多药分离株为L2(P < .001),L2和L4较L3或L1表现出更高的流行病学成功,L4在多变量模型中聚集优势比为5.1(95%CI 2.3-12.3)。

要点

  • L3占612株分离株的44.6%,为最常见谱系。
  • 61.1%的耐多药分离株为L2(P < .001),L2耐药获得率更高且更近期。
  • L4在多变量模型中聚集优势比为5.1(95%CI 2.3-12.3),L2和L4流行病学成功高于L3或L1。

核心结论

  • 在浦那,L2谱系耐药频率更高,L2和L4较L3或L1表现出更高的流行病学成功证据。
  • 作者认为围绕结核病例的接触者追踪和加强印度结核耐药监测是公共卫生优先事项。

研究设计与样本

  • 研究对来自两项前瞻性队列研究参与者的痰培养阳性分离株进行全基因组测序,并使用经过验证的随机森林模型预测基因型药敏。
  • 共612株分离株符合序列质量标准,比较L1-L4谱系的系统发育和时间标度指标以评估流行病学成功。

主要发现

  • 612株分离株中L3占44.6%。
  • 61.1%的耐多药分离株为L2(P < .001),L2耐药获得率更高且更近期。
  • L4和/或L2较L3和/或L1表现出更高的聚集性和时间标度单倍型密度(THD),提示更高的流行病学成功。
  • 在控制宿主因素和耐药的多变量模型中,L4表现出更高的THD和聚集性(比值比5.1,95%CI 2.3-12.3)。

临床怎么用

  • 作者认为围绕结核病例的接触者追踪和加强印度结核耐药监测是公共卫生优先事项。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Drivers of tuberculosis (TB) transmission in India, the country estimated to carry a quarter of the world's burden, are not well studied. We conducted a genomic epidemiology study to compare epidemiological success, host factors, and drug resistance among the 4 major Mycobacterium tuberculosis (Mtb) lineages (L1-L4) circulating in Pune, India. METHODS: We performed whole-genome sequencing (WGS) of Mtb sputum culture-positive isolates from participants in two prospective cohort studies and predicted genotypic susceptibility using a validated random forest model. We compared lineage-specific phylogenetic and time-scaled metrics to assess epidemiological success. RESULTS: Of the 612 isolates that met sequence quality criteria, Most were L3 (44.6%). The majority (61.1%) of multidrug-resistant isolates were L2 (P < .001) and L2 demonstrated a higher rate and more recent resistance acquisition. L4 and/or L2 demonstrated higher clustering and time-scaled haplotypic density (THD) compared to L3 and/or L1, suggesting higher epidemiological success. L4 demonstrated higher THD and clustering (odds ratio, 5.1 [95% confidence interval, 2.3-12.3]) in multivariate models controlling for host factors and resistance. CONCLUSIONS: L2 shows a higher frequency of resistance, and both L2 and L4 demonstrate evidence of higher epidemiological success than L3 or L1 in Pune. Contact tracing around TB cases and heightened surveillance of TB DR in India is a public health priority.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dixit A, Ektefaie Y, Kagal A, et al. Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India. J Infect Dis. 2025. PMID: 38819323. doi:10.1093/infdis/jiae240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。